Market Movers: Amarin (AMRN) Climbs 5.85% to Close at $1.99 June 23

Equities Staff  |

Amarin Corp - ADR (NASDAQ:AMRN) stock was among today's market movers, ending trading up 5.85% to $1.99 on June 23.

2,174,973 shares exchanged hands while the 30-day daily average of 4,619,560 shares.

The company's stock has climbed 44.21% so far in 2022.

Amarin shares have fluctuated between $1.11 and $5.97 over the past twelve months.

The company expects its next earnings on 2022-08-04.

For technical charts, analysis, and more on Amarin visit the company profile.

About Amarin Corp - ADR

Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its commercial expansion, it is evolving and growing. In 2009, Amarin had fewer than twenty employees. Today, with offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, and Zug in Switzerland, Amarin has approximately 1,000 employees and commercial partners and suppliers around the world. It is committed to rethinking cardiovascular risk through the advancement of scientific understanding of the impact on society of significant residual risk that exists beyond traditional therapies, such as statins for cholesterol management.

To get more information on Amarin Corp - ADR and to follow the company's latest updates, you can visit the company's profile page here: Amarin Corp - ADR's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content